Spectroscopy specialist Starna Scientific has appointed Nathan Hulme as a director to help guide the company’s expansion plans.
Hulme’s main responsibilities will include assisting in setting out a business strategy for the company that will address communications with customers and dealers as well as involving leadership of the sales team.
A graduate from Merton College, Oxford University, Hulme has a degree in Philosophy, Politics & Economics (PPE), specialising in Finance and International Economics.
He has also completed a mini-MBA at Tanaka Business School, Imperial College that featured finance, strategy and marketing components.
Starna Scientific appoints Nathan Hulme as a director
To help guide expansion plans at the spectroscopy specialist
You may also like
Regulatory
Analytical vigilance saves lives
The EDQM has updated Ph. Eur. monographs to detect ethylene glycol and diethylene glycol. Butterworth Laboratories supports compliance through validated chromatographic testing, impurity screening, and documentation—helping pharmaceutical companies ensure product safety and protect patient lives
Analysis
Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds
Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals
People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
Analysis
Leica Biosystems expands leading digital pathology portfolio for the US with multiple launches at Pathology Visions 2025
In a groundbreaking showcase of innovation designed to accelerate the digital transformation of pathology, Leica Biosystems proudly launches its latest software solutions in the Aperio Digital Pathology portfolio during Pathology Visions.